Fred G Behm

Author PubWeight™ 26.11^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling.	Cancer Cell	2002	11.83
2	Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.	Cancer Cell	2002	6.64
3	Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia.	JAMA	2007	2.38
4	Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421.	Blood	2005	2.24
5	Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia.	J Clin Oncol	2002	1.12
6	POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group.	J Pediatr Hematol Oncol	2006	1.07
7	Utility of automated counting to determine absolute neutrophil counts and absolute phagocyte counts for pediatric cancer treatment protocols.	Cancer	2004	0.86
8	Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3).	Pediatr Blood Cancer	2014	0.80
9	A complex variant t(8;21) involving chromosome 3 in a child with acute myeloblastic leukemia with eosinophilia (AML M4Eo).	Leuk Lymphoma	2003	0.75